Serum amino acid concentrations and clinical outcomes in smokers: SPIROMICS metabolomics study.

Sci Rep 2019 Aug 6;9(1):11367. Epub 2019 Aug 6.

Division of Pulmonary and Critical Care Medicine, University of Michigan, Ann Arbor, MI, USA.

Metabolomics is an emerging science that can inform pathogenic mechanisms behind clinical phenotypes in COPD. We aimed to understand disturbances in the serum metabolome associated with respiratory outcomes in ever-smokers from the SPIROMICS cohort. We measured 27 serum metabolites, mostly amino acids, by H-nuclear magnetic resonance spectroscopy in 157 white ever-smokers with and without COPD. We tested the association between log-transformed metabolite concentrations and one-year incidence of respiratory exacerbations after adjusting for age, sex, current smoking, body mass index, diabetes, inhaled or oral corticosteroid use, study site and clinical predictors of exacerbations, including FEV% predicted and history of exacerbations. The mean age of participants was 53.7 years and 58% had COPD. Lower concentrations of serum amino acids were independently associated with 1-year incidence of respiratory exacerbations, including tryptophan (β = -4.1, 95% CI [-7.0; -1.1], p = 0.007) and the branched-chain amino acids (leucine: β = -6.0, 95% CI [-9.5; -2.4], p = 0.001; isoleucine: β = -5.2, 95% CI [-8.6; -1.8], p = 0.003; valine: β = -4.1, 95% CI [-6.9; -1.4], p = 0.003). Tryptophan concentration was inversely associated with the blood neutrophil-to-lymphocyte ratio (p = 0.03) and the BODE index (p = 0.03). Reduced serum amino acid concentrations in ever-smokers with and without COPD are associated with an increased incidence of respiratory exacerbations.

Download full-text PDF

Source
http://dx.doi.org/10.1038/s41598-019-47761-wDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6684630PMC
August 2019
1 Read

Publication Analysis

Top Keywords

respiratory exacerbations
12
amino acids
12
incidence respiratory
12
serum amino
12
exacerbations including
8
ever-smokers copd
8
β = -41 95%
8
amino acid
8
acid concentrations
8
serum
5
exacerbations
5
history exacerbations
4
exacerbations age
4
predicted history
4
fev% predicted
4
including fev%
4
age participants
4
copd associated
4
537 years
4
concentrations serum
4

References

(Supplied by CrossRef)

CF Vogelmeier et al.
Am J Respir Crit Care Med 2017

MK Han et al.
Respir Med 2017

JR Hurst et al.
N Engl J Med 2010

HO Coxson et al.
Lancet Respir Med 2013

RP Bowler et al.
Ann Am Thorac Soc 2017

CB Clish et al.
Cold Spring Harb Mol Case Stud 2015

Q Chen et al.
PLoS One 2015

G Laurentiis de et al.
J Proteome Res 2013

M Paige et al.
Biochem Biophys Res Commun 2011

L Wang et al.
PLoS One 2013

F Benedetto De et al.
Respir Med 2018

Similar Publications